Biogen Inc. buy Royal Bank of Canada
Start price
08.10.25
/
50%
€130.40
Target price
08.10.26
€186.64
Performance (%)
14.92%
Price
30.12.25
€149.85
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 14.92%. This prediction currently runs until 08.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 1.045% | 1.045% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $219.00 to $217.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat